HA and AHNP on the nanoparticle surface allowed superior delivery of SN38 to gastric cancer cells by targeting CD44 and HER2, leading to repressed relative signalling cascades and inhibition of cell growth and invasion [224]. This evidence concerns the gene ERBB2 and gastric cancer.